Today: 21 May 2026
NASA orders SpaceX Crew-11 home early after ISS medical issue, targets Jan. 15 splashdown
10 January 2026
1 min read

NASA orders SpaceX Crew-11 home early after ISS medical issue, targets Jan. 15 splashdown

WASHINGTON, Jan 10, 2026, 14:24 EST

  • NASA and SpaceX have scheduled the undocking of Crew-11 from the International Space Station for January 14.
  • NASA confirmed the crew member involved in the medical issue is currently stable
  • Splashdown is set for early Jan. 15 off the California coast, though the exact timing remains weather-dependent

NASA and SpaceX now plan to bring the Crew-11 mission back from the International Space Station no earlier than 5 p.m. ET on Jan. 14, following a medical issue with one crew member, NASA said. The four-person team is expected to splash down off California’s coast around 3:40 a.m. ET on Jan. 15.

This marks the first planned medical evacuation from the ISS in its 25-year history, as NASA struggles to maintain routine operations with less room for error. NASA Administrator Jared Isaacman told reporters the agency expedited the return due to a “serious medical condition,” though the top medical official stressed it was “not an emergent evacuation.” The Guardian

NASA revealed the situation on Jan. 8, confirming it involved one crew member who remains stable. The agency is “actively evaluating all options,” which could mean cutting Crew-11’s mission short. NASA

Crew-11 includes NASA astronauts Zena Cardman and Mike Fincke, along with Japan Aerospace Exploration Agency astronaut Kimiya Yui and Russian cosmonaut Oleg Platonov. NASA hasn’t disclosed which crew member is impacted or provided details on the medical condition, citing privacy concerns.

“Undocking” refers to the SpaceX Dragon capsule detaching from the station and moving away to begin its journey back to Earth. NASA will finalize a precise splashdown time and location nearer to departure, factoring in spacecraft readiness, recovery teams, weather, and sea conditions.

Isaacman explained the choice came down to constraints aboard the station, noting that “the capability to diagnose and treat this properly does not live on the International Space Station.” NASA’s medical lead James Polk clarified the issue wasn’t related to any injury during station activities. Reuters

The schedule is still a target, not set in stone. Weather and sea conditions off California could delay the splashdown window. NASA has built in flexibility to shift timing based on the crew member’s health and evolving recovery plans on the ground.

Once Crew-11 leaves, just three will be left aboard the space station: NASA astronaut Chris Williams plus Russian cosmonauts Sergei Mikayev and Sergei Kud-Sverchkov. NASA says the crew member facing medical issues is stable but is withholding further details.

NASA is also reviewing its staffing and handover schedules, considering an earlier launch for the next crew rotation. According to SpacePolicyOnline, the agency is assessing if Crew-12’s launch can be expedited.

Stock Market Today

  • Thales (ENXTPA:HO) Shares Decline but DCF Model Indicates Undervaluation
    May 21, 2026, 1:56 AM EDT. Shares of Thales (ENXTPA:HO) have fallen 12.8% over the past month and are down 9.7% year on year, despite strong long-term returns of 79.2% and 203.0% over three and five years respectively. Recent sector-specific developments in aerospace and defense, alongside broader market sentiment, contribute to price volatility. A discounted cash flow (DCF) analysis estimates Thales's intrinsic value at around €306.76 per share, suggesting the current price of €229.50 trades at a 25.2% discount and that the stock is undervalued. The P/E ratio remains a key metric but further valuation aspects need evaluation, as Thales scores 4 out of 6 on Simply Wall St's valuation checks. Investors should consider these factors when assessing the stock's potential.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy
Previous Story

Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Next Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

Go toTop